Spinal Fusion Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: June 30, 2023 Report Code: GDME1569EPD-ST

Select Item

Spinal Fusion Market Overview

Spinal fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Spinal fusion is performed by conventional and Minimally Invasive Surgery (MIS) methods. Conventional methods include all open surgical methods that are used for performing spinal procedures. Depending on the site of the incision (surgical approach), thoracolumbar fusion procedures are divided into anterior, posterior and lateral fusion procedures.

 The spinal fusion pipeline market research report provides comprehensive information about the spinal fusion pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segment ·       Interbody devices

·       Pedicle screw systems

·       PEEK interbody devices

·       Spinal plating systems
Key Territories ·       The US

·       Europe

·       China

·       India

·       Australia
Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       TGA

·       ICAC
Leading Companies ·       AMB Surgical II LLC

·       APTO Orthopaedics

·       Aurora Spine Corp

·       Biedermann Motech GmbH & Co KG

·       Bio2 Technologies Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Spinal Fusion Pipeline Market Segments

Some of the key segments in the spinal fusion market are interbody devices, pedicle screw systems, PEEK interbody devices, and spinal plating systems among others. The interbody devices segment is leading in the market in 2023.

Spinal Fusion Pipeline Market Analysis, by Segments, 2023 (%)

Spinal Fusion Pipeline Market Analysis, by Segments, 2023 (%)

For more segments insights into the spinal fusion pipeline market, download a free report sample

Spinal Fusion Pipeline Market Segmentation by Territories

Some of the key territories in the spinal fusion market are the US, Europe, China, India, and Australia among others. As of June 2023, the US has the highest number of pipeline products.

Spinal Fusion Pipeline Market Analysis, by Territories, 2023 (%)

Spinal Fusion Pipeline Market Analysis, by Territories, 2023 (%)

or more territory insights into the spinal fusion pipeline market, download a free report sample

Spinal Fusion Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the spinal fusion pipeline market are 510(k), NMPA, TGA, CE, and ICAC among others. As of June 2023, 510(k) is the most followed pathway for pipeline products.

Spinal Fusion Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Spinal Fusion Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the spinal fusion pipeline market, download a free report sample

Spinal Fusion Pipeline Market – Competitive Landscape

Some of the key companies in the spinal fusion pipeline market are AMB Surgical II LLC, APTO Orthopaedics, Aurora Spine Corp, Biedermann Motech GmbH & Co KG, and Bio2 Technologies Inc among others.

AMB Surgical II LLC: AMB Surgical II LLC, is a developer of FLYTE automated growing rod technology to reduce anxiety and trauma from juvenile and adolescent surgeries. The company is headquartered in United States.

Segments Covered in the Report

Spinal Fusion Pipeline Market Segments Outlook

  • Interbody devices
  • Pedicle screw systems
  • PEEK interbody devices
  • Spinal plating systems

Spinal Fusion Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • India
  • Australia

Spinal Fusion Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • TGA
  • ICAC

Scope

  • Extensive coverage of the spinal fusion under development

  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities

  • Reviews the major players involved in the development of spinal fusion and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of spinal fusion under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3D Systems Inc
Acuitive Technologies Inc
Allegra Orthopaedics Ltd
ALM Ortho Inc
Alphatec Holdings Inc
AMB Surgical II LLC
APTO Orthopaedics
Aurora Spine Corp
Biedermann Motech GmbH & Co KG
Bio2 Technologies Inc
Bioretec Ltd
Butterfly Spine, LLC
Camber Spine Technologies LLC
Choice Spine LLC
Clariance Inc
Clariance SAS
Corelink LLC
Cortical Concepts (Inactive)
CTL Amedica Corp
Cutting Edge Spine LLC
DePuy Synthes Inc
DSM Biomedical BV
DSM Dyneema BV
Eden Spine LLC
EDGe Surgical Inc
Eminent Spine LLC
ErgoSpine
Evoke Medical LLC
FacetMed Ltd
Farmove Medical
Fuse Medical Inc
GS Medical LLC
H. Lee Moffitt Cancer Center & Research Institute Inc
HAPPE Spine LLC
HD LifeSciences LLC
Implanet SA
Innospina LLC
Innov'spine
Intelligent Implant Systems LLC
Intelligent Implants
Jemo Spine, LLC.
joimax GmbH
LESspine LLC
Lifespans Ltd
Mayo Clinic
Medicrea Group
Medtronic Plc
Medyssey Co Ltd
Mekanika Inc
Mercy Health Research
Mesoblast Ltd
MI4 Spine, LLC
Michigan State University
MicroPort Scientific Corp
N8 Medical LLC
Nanovis Inc
Nasseo, Inc.
NEOS Surgery SL
Neumedix Surgical Pty Ltd
Nexilis AG
Nexxt Spine LLC
Novadip Biosciences SA
Novum Medical Products, Inc.
Nutech Medical Inc
NuVasive Inc
Orchid Orthopedic Solutions LLC
Orthobond
OsteoGeneX Inc
OsteoVantage Inc
Ozop Surgical Corp (Inactive)
Pharmaco-Kinesis Corp
Precision Spine Inc
Providence Medical Technology Inc
RegeneEx Ltd.
Resoimplant GmbH (Inactive)
RevBio Inc
ReVivo Medical, LLC
Sail Fusion LLC
SANUWAVE Health Inc
SeaSpine, Inc.
Signus Medical LLC
SINTX Technologies Inc
Spinal Balance Inc.
Spinal Elements Inc
Spinal Resources Inc
Spinal Simplicity LLC
SpinalVu Inc (Inactive)
Spine Wave Inc
SpineGuard SA
SpineSmith Holdings LLC
SpineVision SA
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stryker Corp
Taragenyx Ltd (Inactive)
Theradaptive Inc
Tissue Regeneration Systems, Inc.
TranS1 Inc
TruSpine Technologies Plc
University of Colorado
University of Colorado Anschutz Medical Campus
University of Pittsburgh
University of South Florida
University of Toledo
University of Utah
University of Virginia
VersaSpine LLC
Vertech Inc
Verticor (Inactive)
VGI Medical LLC
White Light Medical
Xtant Medical Holdings Inc
Xtremity & Spinal Solutions Ltd
Yunyi (Beijing) Medical Device Co Ltd
Zyga Technology Inc
ZygoFix Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 10

|1.2 List of Figures 20

2 Introduction 21

2.1 Spinal Fusion Overview 21

3 Products under Development 22

3.1 Spinal Fusion – Pipeline Products by Stage of Development 22

3.2 Spinal Fusion – Pipeline Products by Segment 23

3.3 Spinal Fusion – Pipeline Products by Territory 24

3.4 Spinal Fusion – Pipeline Products by Regulatory Path 25

3.5 Spinal Fusion – Pipeline Products by Estimated Approval Date 26

3.6 Spinal Fusion – Ongoing Clinical Trials 27

4 Spinal Fusion – Pipeline Products under Development by Companies 28

4.1 Spinal Fusion Companies – Pipeline Products by Stage of Development 28

4.2 Spinal Fusion – Pipeline Products by Stage of Development 33

5 Spinal Fusion Companies and Product Overview 38

5.1 3D Systems Inc Company Overview 38

5.1.1 3D Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.2 Acuitive Technologies Inc Company Overview 39

5.2.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.3 Allegra Orthopaedics Ltd Company Overview 40

5.3.1 Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.4 ALM Ortho Inc Company Overview 41

5.4.1 ALM Ortho Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.5 Alphatec Holdings Inc Company Overview 43

5.5.1 Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.6 AMB Surgical II LLC Company Overview 49

5.6.1 AMB Surgical II LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.7 APTO Orthopaedics Company Overview 50

5.7.1 APTO Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview 50

5.8 Aurora Spine Corp Company Overview 51

5.8.1 Aurora Spine Corp Pipeline Products & Ongoing Clinical Trials Overview 51

5.9 Biedermann Motech GmbH & Co KG Company Overview 54

5.9.1 Biedermann Motech GmbH & Co KG Pipeline Products & Ongoing Clinical Trials Overview 54

5.10 Bio2 Technologies Inc Company Overview 55

5.10.1 Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.11 Bioretec Ltd Company Overview 57

5.11.1 Bioretec Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.12 Butterfly Spine, LLC Company Overview 58

5.12.1 Butterfly Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 58

5.13 Camber Spine Technologies LLC Company Overview 59

5.13.1 Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.14 Choice Spine LLC Company Overview 64

5.14.1 Choice Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 64

5.15 Clariance Inc Company Overview 66

5.15.1 Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.16 Clariance SAS Company Overview 67

5.16.1 Clariance SAS Pipeline Products & Ongoing Clinical Trials Overview 67

5.17 Corelink LLC Company Overview 70

5.17.1 Corelink LLC Pipeline Products & Ongoing Clinical Trials Overview 70

5.18 Cortical Concepts (Inactive) Company Overview 73

5.18.1 Cortical Concepts (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73

5.19 CTL Amedica Corp Company Overview 74

5.19.1 CTL Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 74

5.20 Cutting Edge Spine LLC Company Overview 77

5.20.1 Cutting Edge Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 77

5.21 DePuy Synthes Inc Company Overview 79

5.21.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.22 DSM Biomedical BV Company Overview 81

5.22.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 81

5.23 DSM Dyneema BV Company Overview 84

5.23.1 DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview 84

5.24 Eden Spine LLC Company Overview 85

5.24.1 Eden Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 85

5.25 EDGe Surgical Inc Company Overview 86

5.25.1 EDGe Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.26 Eminent Spine LLC Company Overview 87

5.26.1 Eminent Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 87

5.27 ErgoSpine Company Overview 89

5.27.1 ErgoSpine Pipeline Products & Ongoing Clinical Trials Overview 89

5.28 Evoke Medical LLC Company Overview 90

5.28.1 Evoke Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 90

5.29 FacetMed Ltd Company Overview 91

5.29.1 FacetMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.30 Farmove Medical Company Overview 93

5.30.1 Farmove Medical Pipeline Products & Ongoing Clinical Trials Overview 93

5.31 Fuse Medical Inc Company Overview 94

5.31.1 Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.32 GS Medical LLC Company Overview 96

5.32.1 GS Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 96

5.33 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 98

5.33.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 98

5.34 HAPPE Spine LLC Company Overview 99

5.34.1 HAPPE Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 99

5.35 HD LifeSciences LLC Company Overview 102

5.35.1 HD LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview 102

5.36 Implanet SA Company Overview 104

5.36.1 Implanet SA Pipeline Products & Ongoing Clinical Trials Overview 104

5.37 Innospina LLC Company Overview 110

5.37.1 Innospina LLC Pipeline Products & Ongoing Clinical Trials Overview 110

5.38 Innov’spine Company Overview 111

5.38.1 Innov’spine Pipeline Products & Ongoing Clinical Trials Overview 111

5.39 Intelligent Implant Systems LLC Company Overview 112

5.39.1 Intelligent Implant Systems LLC Pipeline Products & Ongoing Clinical Trials Overview 112

5.40 Intelligent Implants Company Overview 114

5.40.1 Intelligent Implants Pipeline Products & Ongoing Clinical Trials Overview 114

5.41 Jemo Spine, LLC. Company Overview 115

5.41.1 Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 115

5.42 joimax GmbH Company Overview 117

5.42.1 joimax GmbH Pipeline Products & Ongoing Clinical Trials Overview 117

5.43 LESspine LLC Company Overview 118

5.43.1 LESspine LLC Pipeline Products & Ongoing Clinical Trials Overview 118

5.44 Lifespans Ltd Company Overview 122

5.44.1 Lifespans Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

5.45 Mayo Clinic Company Overview 123

5.45.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 123

5.46 Medicrea Group Company Overview 124

5.46.1 Medicrea Group Pipeline Products & Ongoing Clinical Trials Overview 124

5.47 Medtronic Plc Company Overview 125

5.47.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 125

5.48 Medyssey Co Ltd Company Overview 128

5.48.1 Medyssey Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 128

5.49 Mekanika Inc Company Overview 129

5.49.1 Mekanika Inc Pipeline Products & Ongoing Clinical Trials Overview 129

5.50 Mercy Health Research Company Overview 130

5.50.1 Mercy Health Research Pipeline Products & Ongoing Clinical Trials Overview 130

5.51 Mesoblast Ltd Company Overview 131

5.51.1 Mesoblast Ltd Pipeline Products & Ongoing Clinical Trials Overview 131

5.52 MI4 Spine, LLC Company Overview 132

5.52.1 MI4 Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 132

5.53 Michigan State University Company Overview 135

5.53.1 Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 135

5.54 MicroPort Scientific Corp Company Overview 136

5.54.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 136

5.55 N8 Medical LLC Company Overview 138

5.55.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 138

5.56 Nanovis Inc Company Overview 139

5.56.1 Nanovis Inc Pipeline Products & Ongoing Clinical Trials Overview 139

5.57 Nasseo, Inc. Company Overview 140

5.57.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 140

5.58 NEOS Surgery SL Company Overview 141

5.58.1 NEOS Surgery SL Pipeline Products & Ongoing Clinical Trials Overview 141

5.59 Neumedix Surgical Pty Ltd Company Overview 142

5.59.1 Neumedix Surgical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 142

5.60 Nexilis AG Company Overview 143

5.60.1 Nexilis AG Pipeline Products & Ongoing Clinical Trials Overview 143

5.61 Nexxt Spine LLC Company Overview 146

5.61.1 Nexxt Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 146

5.62 Novadip Biosciences SA Company Overview 148

5.62.1 Novadip Biosciences SA Pipeline Products & Ongoing Clinical Trials Overview 148

5.63 Novum Medical Products, Inc. Company Overview 149

5.63.1 Novum Medical Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149

5.64 Nutech Medical Inc Company Overview 151

5.64.1 Nutech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 151

5.65 NuVasive Inc Company Overview 152

5.65.1 NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview 152

5.66 Orchid Orthopedic Solutions LLC Company Overview 154

5.66.1 Orchid Orthopedic Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 154

5.67 Orthobond Company Overview 155

5.67.1 Orthobond Pipeline Products & Ongoing Clinical Trials Overview 155

5.68 OsteoGeneX Inc Company Overview 156

5.68.1 OsteoGeneX Inc Pipeline Products & Ongoing Clinical Trials Overview 156

5.69 OsteoVantage Inc Company Overview 157

5.69.1 OsteoVantage Inc Pipeline Products & Ongoing Clinical Trials Overview 157

5.70 Ozop Surgical Corp (Inactive) Company Overview 158

5.70.1 Ozop Surgical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 158

5.71 Pharmaco-Kinesis Corp Company Overview 159

5.71.1 Pharmaco-Kinesis Corp Pipeline Products & Ongoing Clinical Trials Overview 159

5.72 Precision Spine Inc Company Overview 160

5.72.1 Precision Spine Inc Pipeline Products & Ongoing Clinical Trials Overview 160

5.73 Providence Medical Technology Inc Company Overview 161

5.73.1 Providence Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 161

5.74 RegeneEx Ltd. Company Overview 164

5.74.1 RegeneEx Ltd. Pipeline Products & Ongoing Clinical Trials Overview 164

5.75 Resoimplant GmbH (Inactive) Company Overview 165

5.75.1 Resoimplant GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 165

5.76 RevBio Inc Company Overview 166

5.76.1 RevBio Inc Pipeline Products & Ongoing Clinical Trials Overview 166

5.77 ReVivo Medical, LLC Company Overview 167

5.77.1 ReVivo Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 167

5.78 Sail Fusion LLC Company Overview 168

5.78.1 Sail Fusion LLC Pipeline Products & Ongoing Clinical Trials Overview 168

5.79 SANUWAVE Health Inc Company Overview 169

5.79.1 SANUWAVE Health Inc Pipeline Products & Ongoing Clinical Trials Overview 169

5.80 SeaSpine, Inc. Company Overview 170

5.80.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 170

5.81 Signus Medical LLC Company Overview 175

5.81.1 Signus Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 175

5.82 SINTX Technologies Inc Company Overview 176

5.82.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 176

5.83 Spinal Balance Inc. Company Overview 178

5.83.1 Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 178

5.84 Spinal Elements Inc Company Overview 179

5.84.1 Spinal Elements Inc Pipeline Products & Ongoing Clinical Trials Overview 179

5.85 Spinal Resources Inc Company Overview 180

5.85.1 Spinal Resources Inc Pipeline Products & Ongoing Clinical Trials Overview 180

5.86 Spinal Simplicity LLC Company Overview 183

5.86.1 Spinal Simplicity LLC Pipeline Products & Ongoing Clinical Trials Overview 183

5.87 SpinalVu Inc (Inactive) Company Overview 184

5.87.1 SpinalVu Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 184

5.88 Spine Wave Inc Company Overview 186

5.88.1 Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview 186

5.89 SpineGuard SA Company Overview 187

5.89.1 SpineGuard SA Pipeline Products & Ongoing Clinical Trials Overview 187

5.90 SpineSmith Holdings LLC Company Overview 188

5.90.1 SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 188

5.91 SpineVision SA Company Overview 191

5.91.1 SpineVision SA Pipeline Products & Ongoing Clinical Trials Overview 191

5.92 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 192

5.92.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 192

5.93 Stryker Corp Company Overview 193

5.93.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 193

5.94 Taragenyx Ltd (Inactive) Company Overview 196

5.94.1 Taragenyx Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 196

5.95 Theradaptive Inc Company Overview 197

5.95.1 Theradaptive Inc Pipeline Products & Ongoing Clinical Trials Overview 197

5.96 Tissue Regeneration Systems, Inc. Company Overview 198

5.96.1 Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 198

5.97 TranS1 Inc Company Overview 199

5.97.1 TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 199

5.98 TruSpine Technologies Plc Company Overview 200

5.98.1 TruSpine Technologies Plc Pipeline Products & Ongoing Clinical Trials Overview 200

5.99 University of Colorado Company Overview 203

5.99.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 203

5.100 University of Colorado Anschutz Medical Campus Company Overview 204

5.100.1 University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 204

5.101 University of Pittsburgh Company Overview 205

5.101.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 205

5.102 University of South Florida Company Overview 206

5.102.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 206

5.103 University of Toledo Company Overview 210

5.103.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 210

5.104 University of Utah Company Overview 216

5.104.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 216

5.105 University of Virginia Company Overview 217

5.105.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 217

5.106 VersaSpine LLC Company Overview 218

5.106.1 VersaSpine LLC Pipeline Products & Ongoing Clinical Trials Overview 218

5.107 Vertech Inc Company Overview 219

5.107.1 Vertech Inc Pipeline Products & Ongoing Clinical Trials Overview 219

5.108 Verticor (Inactive) Company Overview 220

5.108.1 Verticor (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 220

5.109 VGI Medical LLC Company Overview 221

5.109.1 VGI Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 221

5.110 White Light Medical Company Overview 222

5.110.1 White Light Medical Pipeline Products & Ongoing Clinical Trials Overview 222

5.111 Xtant Medical Holdings Inc Company Overview 223

5.111.1 Xtant Medical Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 223

5.112 Xtremity & Spinal Solutions Ltd Company Overview 224

5.112.1 Xtremity & Spinal Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 224

5.113 Yunyi (Beijing) Medical Device Co Ltd Company Overview 226

5.113.1 Yunyi (Beijing) Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 226

5.114 Zyga Technology Inc Company Overview 227

5.114.1 Zyga Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 227

5.115 ZygoFix Ltd Company Overview 228

5.115.1 ZygoFix Ltd Pipeline Products & Ongoing Clinical Trials Overview 228

6 Spinal Fusion – Recent Developments 234

6.1 Jun 14, 2023: SpineGuard Announces Second Call of the Annual Shareholders’ Meeting on June 29, 2023 234

6.2 May 26, 2023: Bioretec announces Resolutions of annual general meeting 234

6.3 May 23, 2023: Aurora Spine schedules release of Q1 fiscal year 2023 financial results and conference call 236

6.4 May 22, 2023: BioSenic provides Q1 2023 business update 236

6.5 May 18, 2023: Centinel Spine announces record worldwide motion preservation revenue in first quarter 2023 238

6.6 May 16, 2023: Former U.S. White House Surgeon and FDA Medical Officer joins Bioretec team 239

6.7 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 239

6.8 May 05, 2023: Bioretec Notice of Annual General Meeting 239

6.9 May 04, 2023: NuVasive announces conference call and webcast of Q1 2023 results 244

6.10 Apr 27, 2023: BioSenic Announces 2022 Full Year Results 244

6.11 Apr 27, 2023: Xtant Medical to issue First Quarter 2023 financial results on May 4, 2023 247

6.12 Apr 26, 2023: Aurora Spine schedules release of Q4 and fiscal year 2022 financial results and conference call 248

6.13 Apr 26, 2023: Orthofix Medical schedules Q1 earnings release and conference call for May 9, 2023 248

6.14 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 248

6.15 Apr 13, 2023: SpineGuard Announces Its Full-year 2022 Financial Results and Its First Quarter 2023 Sales 251

6.16 Apr 13, 2023: Safe group announces revenues of €1.5 million in Q1 2023 254

6.17 Apr 12, 2023: Medtronic has a layoff in California 255

6.18 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 255

6.19 Apr 03, 2023: BioSenic appoints Lieven Huysse MD as Chief Medical Officer 255

6.20 Mar 31, 2023: OrthoPediatrics Leading Sponsorship at Annual EPOS Meeting 256

6.21 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 257

6.22 Mar 16, 2023: Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023 257

6.23 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 257

6.24 Mar 08, 2023: Geisinger Health Plan, Medacta announce first spinal fusion lifetime guarantee 257

6.25 Mar 07, 2023: Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results 258

6.26 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 259

6.27 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 259

6.28 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 259

6.29 Feb 21, 2023: Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023 261

6.30 Feb 17, 2023: Bioretec Announces financial statements bulletin 2022 261

6.31 Feb 14, 2023: Spineway Reports Full Year 2022 Earnings 263

6.32 Feb 09, 2023: Spinal Elements Appoints Ron Lloyd as President and Chief Executive Officer 263

6.33 Feb 09, 2023: Spineway announces 2022 annual results 263

6.34 Feb 03, 2023: Medacta Group reports a robust

20.4% revenue growth in 2022 reaching

437.1 M€ 264

6.35 Jan 27, 2023: BioSenic appoints Yves Sagot as Independent Director 265

6.36 Jan 25, 2023: Tyber Medical Names James Abraham and Damien Sibilla to Executive Leadership Team 266

6.37 Jan 24, 2023: IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31% 266

6.38 Jan 18, 2023: BioSenic appoints Dr Carole Nicco as Chief Scientific Officer 268

6.39 Jan 09, 2023: Orthofix Medical Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results 268

6.40 Jan 09, 2023: ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility 271

6.41 Jan 09, 2023: SpineGuard Reports a +37% Increase in Q4 2022 Revenue 272

6.42 Dec 20, 2022: Bioretec’s financial information and Annual General Meeting in 2023 273

6.43 Dec 19, 2022: Spineart and eCential Robotics annouce a partnership to co-develop spine surgery applications and co-market the eCential Robotics’ open robotic surgery platform 273

6.44 Dec 02, 2022: BioSenic appoints Michel Wurm, M.D. as Chief Medical Officer 274

6.45 Nov 23, 2022: Medtronic Reports Quarterly Earnings 275

6.46 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 275

6.47 Nov 22, 2022: Mesoblast Reports Financial Results and Operational Highlights for the Period Ended September 30, 2022 281

6.48 Nov 21, 2022: Mesoblast Financial Results and Corporate Update Webcast 283

6.49 Nov 21, 2022: Aurora Spine Announces Third Quarter Fiscal 2022 Financial Results 283

6.50 Nov 21, 2022: Hogan Lovells advises Stumpf Group on minority investment by funds managed by BDT Capital Partners in Exyte Group 284

6.51 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 285

6.52 Nov 10, 2022: Surgalign aims to slash $30M from 2023 spending with planned layoffs 285

6.53 Nov 09, 2022: Safe announces the convocation of an extraordinary general meeting of the Company to be held on December 16, 2022 285

6.54 Nov 07, 2022: NuVasive launches tube system and excavation micro for posterior spine surgery 285

6.55 Oct 30, 2022: Mesoblast Operational and Financial Highlights for Quarter Ended September 30, 2022 286

6.56 Oct 27, 2022: Xtant Medical to Issue Third Quarter 2022 Financial Results on November 3, 2022 286

6.57 Oct 25, 2022: Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022 287

6.58 Oct 19, 2022: Allosource Announces Dean Elliott as New President and CEO 287

6.59 Oct 12, 2022: Aurora Spine Corporation to Attend the North American Spine Society Annual Meeting 287

6.60 Oct 11, 2022: Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting 288

6.61 Oct 11, 2022: Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results 289

6.62 Oct 10, 2022: ATEC Announces Select Preliminary Third Quarter 2022 Financial Results and Raises Guidance 291

6.63 Oct 06, 2022: Safe group announces its first semester financial results and Q3 sales 291

6.64 Oct 06, 2022: Integra LifeSciences appoints Harvinder Singh as Executive Vice President, President Of Co.”s International Business 293

6.65 Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment 293

6.66 Oct 04, 2022: Exactech Names New Chief Financial Officer 294

6.67 Sep 20, 2022: Implanet Publishes its 2022 Half-year Results 294

6.68 Sep 14, 2022: Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference 296

6.69 Sep 12, 2022: NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting 296

6.70 Sep 07, 2022: Bone Therapeutics reports half year 2022 results 297

6.71 Sep 07, 2022: Medtronic to appear at September investor conferences 298

6.72 Aug 30, 2022: ATEC to Participate in Upcoming Investor Conferences 299

6.73 Aug 30, 2022: Mesoblast Reports Financial Results and Operational Highlights for Fiscal Year Ended June 30, 2022 299

6.74 Aug 23, 2022: New Chief Financial Officer Appointment Strengthens Spineology’s Executive Leadership Team 302

6.75 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 302

6.76 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 305

6.77 Aug 12, 2022: Sintx Technologies Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 308

6.78 Aug 09, 2022: Mesoblast shares slide on $65m capital raise announcement 309

6.79 Aug 09, 2022: Kuros Biosciences reports results for the first six months of 2022 309

6.80 Aug 04, 2022: ATEC Reports Second Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance 310

6.81 Aug 03, 2022: Orthopediatrics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance 310

6.82 Aug 02, 2022: Allosource Announces President and CEO Retirement 314

6.83 Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results 314

6.84 Jul 29, 2022: Medacta Group reports

19.0% growth of half-year revenue 315

6.85 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results 315

6.86 Jul 28, 2022: Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022 316

6.87 Jul 26, 2022: ATEC to Participate in Upcoming Investor Conferences 317

6.88 Jul 21, 2022: ATEC to Report Second Quarter 2022 Financial Results on August 4 2022 317

6.89 Jul 12, 2022: SpineGuard Posts 20% Revenue Growth in Q2-2022 317

6.90 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue 318

6.91 Jul 11, 2022: Implanet Reports Its Revenue for Q2 2022, Up 33% 319

6.92 Jul 09, 2022: Shanghai Sanyou Medical Co. Announces appointment of senior management personnel and securities affairs representatives 320

7 Appendix 321

7.1 Methodology 321

7.2 About GlobalData 324

7.3 Contact Us 324

7.4 Disclaimer 324

Frequently asked questions

Spinal Fusion Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Spinal Fusion Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Spinal Fusion reports
Medical Devices
Intuitive Surgical Inc - Company Profile
$295 | April 2023
Medical Devices
Hologic Inc - Company Profile
$295 | April 2023
Medical Devices
Becton Dickinson and Co - Company Profile
$295 | April 2023
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Spinal Fusion Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Spinal Fusion Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more